Proprietary drugs that extend or improve the lives of millions of people have lifted stocks of the biotech companies that own them and made millionaires of many scientists and doctors behind them.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 06/24/2016 - 3:43pm
Proprietary drugs that extend or improve the lives of millions of people have lifted stocks of the biotech companies that own them and made millionaires of many scientists and doctors behind them.